Publication | Closed Access

A phase I-II study of the histone deacetylase inhibitor vorinostat plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in locally advanced breast cancer

Advanced Breast CancerBreast OncologyOncologySequential Weekly PaclitaxelMedicinePhase I-ii StudyBreast CancerAnti-cancer AgentCancer TreatmentPharmacologyRadiation Oncology